Regeneron Pharmaceuticals (REGN)
NASDAQ:REGN
Want to see REGN full AI Analyst Report?
Regeneron (REGN) Ownership Overview
1.98% Insiders
25.11% Mutual Funds
18.48% Other Institutional Investors
29.32% ETFs
25.10% Public Companies and Individual Investors
The ownership structure of Regeneron (REGN) stock is a mix of institutional, retail, and individual investors. Approximately 72.91% of the company’s stock is owned by Institutional Investors, 1.98% is owned by Insiders, and 25.10% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 10, 2025 | xxxxxxxxxxxxx | $280766 | |
Oct 31, 2025 | xxxxxxxxxxxxx | $4252745 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $3444613008 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $17557471 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $3908786 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $505307 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,082,607 | Institution | 7.85% | 4,947,687,049 | |
| 6,945,247 | Institution | 6.74% | 4,251,463,499 | |
| 5,285,306 | Institution | 5.13% | 3,235,347,215 | |
| 4,458,238 | Institution | 4.33% | 2,729,065,809 | |
| 4,101,902 | Institution | 3.98% | 2,510,938,290 | |
| 4,054,664 | Institution | 3.94% | 2,482,022,021 | |
| 3,411,656 | Institution | 3.31% | 2,088,411,104 | |
| 2,194,568 | Institution | 2.13% | 1,343,382,856 | |
| 1,912,262 | Institution | 1.86% | 1,170,572,061 | |
| 1,772,358 | Institution | 1.72% | 1,084,931,226 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,945,247 | Institution | 6.74% | 4,251,463,499 | |
| 3,411,656 | Institution | 3.31% | 2,088,411,104 | |
| 1,772,358 | Institution | 1.72% | 1,084,931,226 | |
| 1,082,054 | Institution | 1.05% | 662,368,536 | |
| 806,416 | Institution | 0.78% | 493,639,490 | |
| 760,952 | Institution | 0.74% | 465,809,157 | |
| 622,681 | Institution | 0.60% | 381,167,947 | |
| 618,380 | Institution | 0.60% | 378,535,133 | |
| 602,903 | Institution | 0.59% | 369,061,042 | |
| 511,945 | Institution | 0.50% | 313,382,012 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,310,556 | Institution | 3.21% | 2,340,761,725 | |
| 2,613,980 | Institution | 2.54% | 1,848,240,699 | |
| 2,226,244 | Institution | 2.16% | 1,361,303,681 | |
| 1,265,296 | Institution | 1.23% | 774,538,293 | |
| 1,235,353 | Institution | 1.20% | 755,393,652 | |
| 1,207,883 | Institution | 1.17% | 905,235,836 | |
| 963,082 | Institution | 0.93% | 680,956,759 | |
| 750,997 | Institution | 0.73% | 459,219,646 | |
| 750,116 | Institution | 0.73% | 459,176,008 | |
| 712,221 | Institution | 0.69% | 435,508,897 |
FAQ
Who Owns Regeneron Pharmaceuticals (REGN)?
According to the latest TipRanks data, approximately 18.48% of the company's stock is held by institutional investors, 1.98% is held by insiders, and 25.10% is held by retail investors.
What percentage of Regeneron Pharmaceuticals (REGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.48% of Regeneron Pharmaceuticals (REGN) stock is held by institutional investors.
What percentage of Regeneron Pharmaceuticals (REGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.10% of Regeneron Pharmaceuticals (REGN) stock is held by retail investors.
Who owns the most shares of Regeneron Pharmaceuticals (REGN)?
Vanguard owns the most shares of Regeneron Pharmaceuticals (REGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.